Skip to main content
. 2016 Feb 11;44(9):4189–4199. doi: 10.1093/nar/gkw087

Figure 4.

Figure 4.

Effect of RAD52 inhibitors on survival of MDA-MB-436 (BRCA1) and [MDA-MB-436 (BRCA1+)] (BRCA1+) cells (A) and on survival of on BCR-ABL1 –positive BRCA1-deficient CML cells and their BRCA1-proficient normal counterparts (B). The experiments were repeated at least three times, error bars indicate SD.